Business

Teva to pay $512 million in Provigil settlement – report

“Reuters” said the settlement would be the largest ever paid over allegations of delaying generic drugs.

Published

April 20, 2015

Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) has agreed to pay $512 million to settle a class action suit, reports “Reuters.” The class action claims that Cephalon Inc., which Teva bought in 2011, “used anticompetitive settlements to delay generic versions of its wakefulness drug Provigil, according to court papers, ” says “Reuters.”

–

Published by Globes [online], Israel business news – www.globes-online.com

In this article:Teva Pharmaceutical Industries Ltd.(NYSE: TEVA; TASE: TEVA), settlement, Finance

World News

Good News From Israel

In the 15th Nov 2015 edition of Israel’s good news, the highlights include: · A new Israeli treatment brings hope to relapsed leukemia...

Michael OrdmanNovember 15, 2015

Life-Style Health

Why search Dr. Google when you can hire a Real Personal Health Researcher?

Medint’s medical researchers provide data-driven insights to help patients make decisions; It is affordable- hundreds rather than thousands of dollars

Abigail Klein LeichmanFebruary 4, 2018

Entertainment

Natalie Portman Regrets Being Made a Lolita and Sexualized as a Child

The Movie The Professional is what made Natalie Portman a Lolita.

Reggie ReinerDecember 9, 2020

Travel

Rating Israeli hotels

After two decades without a rating system in Israel, at the end of 2012 an international tender for hotel rating was published. Invited to place bids...

Jewish Business NewsJanuary 1, 2013

Jewish Business News